Recommendations of diagnosis and treatment of juvenile idiopathic arthritis in China
10.3760/cma.j.cn112138-20210929-00666
- VernacularTitle:幼年特发性关节炎诊疗规范
- Author:
Caifeng LI
1
;
Xinxiang HUANG
;
Yongfu WANG
;
Zhaohui ZHENG
;
Yanyan HUANG
;
Wen ZHANG
;
Yan ZHAO
Author Information
1. 国家儿童医学中心 首都医科大学附属北京儿童医院风湿免疫科，北京100045
- Keywords:
Juvenile idiopathic arthritis;
Diagnosis;
Treatments;
Prognosis
- From:
Chinese Journal of Internal Medicine
2022;61(2):142-156
- CountryChina
- Language:Chinese
-
Abstract:
The common clinical subtypes of juvenile idiopathic arthritis (JIA) include systemic onset juvenile idiopathic arthritis (SOJIA), oligoarthritis/polyarthritis juvenile idiopathic arthritis and juvenile spondyloarthritis. Juvenile idiopathic arthritis has no specific diagnostic index, and needs to be differentiated from infectious diseases and malignant diseases. The onset of SOJIA is rapid, the disease progresses rapidly, and it is easy to be complicated with macrophage activation syndrome (MAS) which is life-threatening. The experience of pediatric rheumatologists in dealing with JIA is still insufficient, and the standardized diagnosis and treatment level of this disease needs to be further improved. Based on the experience and guidelines of diagnosis and treatment in China and abroad, we formulated this diagnosis and treatment standard, aiming at standardizing the diagnosis and treatment of the subtypes of JIA and MAS, so as to reduce the incidence of disability and serious complications and improve the prognosis.
